Omics and Drug Response

被引：106
作者：
Meyer, Urs A. [1 ]
Zanger, Ulrich M. [2 ]
Schwab, Matthias [2 ,3 ]
机构：
[1] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[3] Univ Tubingen Hosp, Dept Clin Pharmacol, D-72076 Tubingen, Germany
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 | 2013年 / 53卷
关键词：
genomic medicine; personalized medicine; pharmacogenetics; pharmacogenomics; biomarkers; genotype-phenotype; GENOME-WIDE ASSOCIATION; IMPLEMENTATION CONSORTIUM GUIDELINES; ACUTE LYMPHOBLASTIC-LEUKEMIA; SYSTEMS BIOLOGY APPROACH; BREAST-CANCER PATIENTS; COLORECTAL-CANCER; HYPERSENSITIVITY REACTIONS; MISSING HERITABILITY; CLINICAL DEVELOPMENT; GENETIC-VARIATION;
D O I：
10.1146/annurev-pharmtox-010510-100502
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A new generation of technologies commonly named omics permits assessment of the entirety of the components of biological systems and produces an explosion of data and a major shift in our concepts of disease. These technologies will likely shape the future of health care. One aspect of these advances is that the data generated document the uniqueness of each human being in regard to disease risk and treatment response. These developments have reemphasized the concept of personalized medicine. Here we review the impact of omics technologies on one key aspect of personalized medicine: the individual drug response. We describe how knowledge of different omics may affect treatment decisions, namely drug choice and drug dose, and how it can be used to improve clinical outcomes.
引用
收藏
页码：475 / 502
页数：28
相关论文
共 198 条
  • [1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
    Aithal, GP
    Day, CP
    Kesteven, PJL
    Daly, AK
    [J]. LANCET, 1999, 353 (9154) : 717 - 719
  • [2] A map of human genome variation from population-scale sequencing
    Altshuler, David
    Durbin, Richard M.
    Abecasis, Goncalo R.
    Bentley, David R.
    Chakravarti, Aravinda
    Clark, Andrew G.
    Collins, Francis S.
    De la Vega, Francisco M.
    Donnelly, Peter
    Egholm, Michael
    Flicek, Paul
    Gabriel, Stacey B.
    Gibbs, Richard A.
    Knoppers, Bartha M.
    Lander, Eric S.
    Lehrach, Hans
    Mardis, Elaine R.
    McVean, Gil A.
    Nickerson, DebbieA.
    Peltonen, Leena
    Schafer, Alan J.
    Sherry, Stephen T.
    Wang, Jun
    Wilson, Richard K.
    Gibbs, Richard A.
    Deiros, David
    Metzker, Mike
    Muzny, Donna
    Reid, Jeff
    Wheeler, David
    Wang, Jun
    Li, Jingxiang
    Jian, Min
    Li, Guoqing
    Li, Ruiqiang
    Liang, Huiqing
    Tian, Geng
    Wang, Bo
    Wang, Jian
    Wang, Wei
    Yang, Huanming
    Zhang, Xiuqing
    Zheng, Huisong
    Lander, Eric S.
    Altshuler, David L.
    Ambrogio, Lauren
    Bloom, Toby
    Cibulskis, Kristian
    Fennell, Tim J.
    Gabriel, Stacey B.
    [J]. NATURE, 2010, 467 (7319) : 1061 - 1073
  • [3] Integrating common and rare genetic variation in diverse human populations
    Altshuler, David M.
    Gibbs, Richard A.
    Peltonen, Leena
    Dermitzakis, Emmanouil
    Schaffner, Stephen F.
    Yu, Fuli
    Bonnen, Penelope E.
    de Bakker, Paul I. W.
    Deloukas, Panos
    Gabriel, Stacey B.
    Gwilliam, Rhian
    Hunt, Sarah
    Inouye, Michael
    Jia, Xiaoming
    Palotie, Aarno
    Parkin, Melissa
    Whittaker, Pamela
    Chang, Kyle
    Hawes, Alicia
    Lewis, Lora R.
    Ren, Yanru
    Wheeler, David
    Muzny, Donna Marie
    Barnes, Chris
    Darvishi, Katayoon
    Hurles, Matthew
    Korn, Joshua M.
    Kristiansson, Kati
    Lee, Charles
    McCarroll, Steven A.
    Nemesh, James
    Keinan, Alon
    Montgomery, Stephen B.
    Pollack, Samuela
    Price, Alkes L.
    Soranzo, Nicole
    Gonzaga-Jauregui, Claudia
    Anttila, Verneri
    Brodeur, Wendy
    Daly, Mark J.
    Leslie, Stephen
    McVean, Gil
    Moutsianas, Loukas
    Nguyen, Huy
    Zhang, Qingrun
    Ghori, Mohammed J. R.
    McGinnis, Ralph
    McLaren, William
    Takeuchi, Fumihiko
    Grossman, Sharon R.
    [J]. NATURE, 2010, 467 (7311) : 52 - 58
  • [4] A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)
    Anderson, Jeffrey L.
    Horne, Benjamin D.
    Stevens, Scott M.
    Woller, Scott C.
    Samuelson, Kent M.
    Mansfield, Justin W.
    Robinson, Michelle
    Barton, Stephanie
    Brunisholz, Kim
    Mower, Chrissa P.
    Huntinghouse, John A.
    Rollo, Jeffrey S.
    Siler, Dustin
    Bair, Tami L.
    Knight, Stacey
    Muhlestein, Joseph B.
    Carlquist, John F.
    [J]. CIRCULATION, 2012, 125 (16) : 1997 - +
  • [5] Genomes by the thousand
    不详
    [J]. NATURE, 2010, 467 (7319) : 1026 - 1027
  • [6] [Anonymous], MLO MED LAB OBS
  • [7] [Anonymous], MLO MED LAB OBS
  • [8] RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity (Publication with Expression of Concern. See vol. 73, pg. 1297, 2020) (Publication with Expression of Concern. See vol. 69, pg. 1402, 2018) (Retracted article. See vol. 73, pg. 1297, 2020)
    Antoine, Daniel J.
    Jenkins, Rosalind E.
    Dear, James W.
    Williams, Dominic P.
    McGill, Mitchell R.
    Sharpe, Matthew R.
    Craig, Darren G.
    Simpson, Kenneth J.
    Jaeschke, Hartmut
    Park, B. Kevin
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1070 - 1079
  • [9] Argiles G, 2012, FUTURE ONCOL, V8, P373, DOI [10.2217/FON.12.20, 10.2217/fon.12.20]
  • [10] Treatment of HER2-positive breast cancer: current status and future perspectives
    Arteaga, Carlos L.
    Sliwkowski, Mark X.
    Osborne, C. Kent
    Perez, Edith A.
    Puglisi, Fabio
    Gianni, Luca
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) : 16 - 32
12345678910